To help stop the rapidly expanding spread of COVID-19 and provide critical instrumentation for respiratory medical equipment, Sierra Instruments offers scientists, biomedical engineers and bioreactor manufacturers a comprehensive line of mass flow controllers to meet demanding bioprocessing applications. The RedySmart is specifically designed and engineered to improve bioreactor performance, employing a stable no-drift MEMS sensor to quickly bring vaccines to full-scale production, while Sierra's flagship SmartTrak 100 provides scientists the application flexibility and accuracy required for laboratory, biomedical and respiratory medical equipment testing.
Built with stable MEMs sensor technology, the RedySmart mass flow controller is designed to improve bioreactor performance with its no drift capability, modular design, flexible cabling system and easy integration into a gas mixing block. It also features digital communication options with Modbus included at no additional charge. Sierra's SmartTrak 100 employs capillary thermal technology, offering scientists and researchers accuracy and application flexibility with one mass flow controller.
Both RedySmart and the SmartTrak 100 share the advantages of being thermal mass flow controllers, providing mass flow not volumetric flow, which is the critical output needed for accurate research data. They contain no moving parts and are unaffected by upstream temperature and pressure fluctuations, resulting in exceptional accuracy and repeatability, according to the company. Sierra also performs a NIST-Traceable calibration over the entire flow range of each instrument, guaranteeing the best possible system accuracies.